The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

Yu-Chi Lee; Tsung-Hui Hu; Chao-Hung Hung; Sheng-Nan Lu; Chien-Hung Chen; Jing-Houng Wang

doi:10.1371/journal.pone.0214323

Loading metrics

Open Access

Peer-reviewed

Research Article

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

Yu-Chi Lee,

Roles Writing – original draft

Affiliation Division of Hepato-Gastroenterology, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung City, Taiwan
⨯
Tsung-Hui Hu,

Roles Resources

Affiliation Division of Hepato-Gastroenterology, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung City, Taiwan
⨯
Chao-Hung Hung,

Roles Resources

Affiliations Division of Hepato-Gastroenterology, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung City, Taiwan, Division of Hepato-Gastroenterology, Department of Medicine, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi City, Taiwan
⨯
Sheng-Nan Lu,

Roles Resources

Affiliations Division of Hepato-Gastroenterology, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung City, Taiwan, Division of Hepato-Gastroenterology, Department of Medicine, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi City, Taiwan
⨯
Chien-Hung Chen,

Roles Resources, Supervision

Affiliation Division of Hepato-Gastroenterology, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung City, Taiwan
⨯
Jing-Houng Wang

Roles Formal analysis, Resources, Supervision

* E-mail: wajing@cgmh.org.tw

Affiliation Division of Hepato-Gastroenterology, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung City, Taiwan
⨯

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

Yu-Chi Lee,
Tsung-Hui Hu,
Chao-Hung Hung,
Sheng-Nan Lu,
Chien-Hung Chen,
Jing-Houng Wang

Published: April 2, 2019
https://doi.org/10.1371/journal.pone.0214323

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Liver fibrosis
Is the Subject Area "Liver fibrosis" applicable to this article?

Thanks for your feedback.
Fatty liver
Is the Subject Area "Fatty liver" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Cirrhosis
Is the Subject Area "Cirrhosis" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Aminotransferases
Is the Subject Area "Aminotransferases" applicable to this article?

Thanks for your feedback.
Chronic hepatitis
Is the Subject Area "Chronic hepatitis" applicable to this article?

Thanks for your feedback.